Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
$11M 30.5%
Total revenue, Q2 '26 ().

Did Abeona Therapeutics Beat Earnings?

Abeona Therapeutics (ABEO) reported Q2 '26 revenue of $11M, up 2,745.0% year-over-year.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Abeona Therapeutics’s job postings, web traffic, and employee business outlook. See the full ABEO stock analysis or the earnings calendar for upcoming reports.

Abeona Therapeutics Quarterly Financial Trends ()

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue—4.8M—400,000—5.4M8.7M11M
Gross margin—-16.2%—75.0%—47.7%59.1%63.3%
Operating margin—-348.6%—-5,698.0%—-422.7%-264.1%-120.0%
Net income-30M-9.3M-12M109M-5.2M-20M-17M-20M
Net margin—-194.3%—27,208.3%—-377.5%-195.8%-177.4%
EPS————————

Abeona Therapeutics Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Abeona Therapeutics’s quarterly revenue moved from $0 to $11M.

When Is Abeona Therapeutics’s Next Earnings Date?

Abeona Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the ABEO earnings calendar.

Frequently Asked Questions: Abeona Therapeutics Earnings

Abeona Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Abeona Therapeutics reported Q2 '26 revenue of $11M, up 2,745.0% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the ABEO AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.